Geffken Daniel E. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Dec 1, 2021
Insider Transaction Report
Form 4
Geffken Daniel E.
CHIEF FINANCIAL OFFICER
Transactions
- Purchase
Common Stock
2021-11-29$0.72/sh+50,000$36,000→ 50,000 total
Footnotes (1)
- [F1]Price represents the average purchase price per share.